2012 annual financial data

Heron Therapeutics 2012 Operating margin

Heron Therapeutics 2012 operating margin with verified reported values.

Direct answer

Operating margin was 3,978.46%.

Operating income was -23,831,000 USD and net income was -23,348,000 USD.
Operating cash flow was -17,009,000 USD.

Get free Heron Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
-599,000 USD
Operating income
-23,831,000 USD
Net income
-23,348,000 USD
Operating cash flow
-17,009,000 USD